Zhiping Peng

Zhiping Peng


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
CZchunbao zang
chunbao zang
XLXujie Liu
Xujie Liu
BLBing Li
Bing Li
YHYanqiong He
Yanqiong He
SJShen Jing
Shen Jing
ZPZhiping Peng
Zhiping Peng
IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma

3 March 2020 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
XCXiaoliang Chen
Xiaoliang Chen
DZDongliang Zhai
Dongliang Zhai
BWBochu Wang
Bochu Wang
SHShilei Hao
Shilei Hao
JSJia Song
Jia Song
ZPZhiping Peng
Zhiping Peng

28 February 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MTMin Tang
Min Tang
YHYan-Li Hou
Yan-Li Hou
QKQiang-Qiang Kang
Qiang-Qiang Kang
XCXing-Yue Chen
Xing-Yue Chen
LDLi-Qun Duan
Li-Qun Duan
ZPZhiping Peng
Zhiping Peng
All-trans-retinoic Acid Promotes Iodine Uptake Via Up-regulating the Sodium Iodide Symporter in Medullary Thyroid Cancer Stem Cells ATRA;medullary thyroid carcinoma stem cells;the capability of radioiodine uptake;$^{131}I$; Recently, the main therapy of medullary thyroid cancer (MTC) is surgical, but by which way there is a poor prognosis with a mean survival of only 5 years. In some cases, some researchers found that it is the medullary thyroid cancer stem cells (MTCSCs) that cause metastasis and recurrence. This study aimed to eradicate MTCSCs through administration of all-trans-retinoic acid (ATRA). Here we demonstrate that MTCSCs possess stemlike properties in serum-free medium. The ABCG2, OCT4 and sodium iodide symporter (NIS) were changed by ATRA. Additionally, we found that ATRA can increase the expression of NIS in vivo. All the data suggested that ATRA could increase the iodine uptake of MTCSCs through NIS.

1 June 2020 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
LWLiang Wang
Liang Wang
MNMengda Niu
Mengda Niu
YHYujia He
Yujia He
CTChuanhuizi Tian
Chuanhuizi Tian
ZPZhiping Peng
Zhiping Peng
JJJianhua Jia
Jianhua Jia

31 March 2023 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JJJianhua Jia
Jianhua Jia
LYLan Yi
Lan Yi
ZXZhu Xia
Zhu Xia
MYMeixian Yang
Meixian Yang
DQDachuan Qiu
Dachuan Qiu
ZPZhiping Peng
Zhiping Peng

1 January 2022 in Molecular Imaging
Verified
Journal Article
Open access
PDF file
MNMengda Niu
Mengda Niu
JQJingjing Qin
Jingjing Qin
LWLiang Wang
Liang Wang
YHYujia He
Yujia He
CTChuanhuizi Tian
Chuanhuizi Tian
ZPZhiping Peng
Zhiping Peng
[18F]tetrafluoroborate (TFB) has been introduced as the 18F-labeled PET imaging probe for the human sodium iodide symporter (NIS). Noninvasive NIS imaging using [18F]TFB has received much interest in recent years for evaluating various NIS-expressing tumors. Cancers are a global concern with enormous implications; therefore, improving diagnostic methods for accurate detection of cancer is extremely important. Our aim was to investigate the PET imaging capabilities of [18F]TFB in NIS-transfected lung cell line A549 and endogenous NIS-expressing tumor cells, such as thyroid cancer K1 and gastric cancer MKN45, and broaden its application in the medical field. Western blot and flow cytometry were used to assess the NIS expression level. Radioactivity counts of [18F]TFB, in vitro, in the three tumor cells were substantially higher than those in the KI inhibition group in the uptake experiment. In vivo PET imaging clearly delineated the three tumors based on the specific accumulation of [18F]TFB in a mouse model. Ex vivo biodistribution investigation showed high [18F]TFB absorption in the tumor location, which was consistent with the PET imaging results. These results support the use of NIS-transfected lung cell line A549 and NIS-expressing tumor cells MKN45 and K1, to investigate probing capabilities of [18F]TFB. We also demonstrate, for the first time, the feasibility of [18F]TFB in diagnosing stomach cancer. In conclusion, this study illustrates the promising future of [18F]TFB for tumor diagnosis and NIS reporter imaging.